Close Menu
    Quick Access
    • Bigg-Boss
    • Entertainment
    • High Life
    • Infotainment
    • News
      • Business
      • Sports
      • Technology
    • News Wire
    • Photo Gallery
    • Stars-Wiki
    • Trending
    • World
    Facebook X (Twitter) Instagram
    • About
    • Contribute
    • Intern
    • Advertise
    • Download the App
    • Contact Us
    Facebook X (Twitter) Pinterest
    PagalParrotPagalParrot
    • Entertainment
    • Infotainment
    • News
      • Sports
      • Business
      • Technology
      • World
    • High Life
    • Trending
    PagalParrotPagalParrot
    Home»News»People over 18 years of age are now eligible for the corona vaccine, but this challenge too
    News

    People over 18 years of age are now eligible for the corona vaccine, but this challenge too

    ShavvyBy ShavvyApril 21, 20214 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Corona vaccine India
    Share
    Facebook Twitter LinkedIn Pinterest Email
    Table of Contents
    • 1 Vaccine availability big crisis
    • 2 It may take time for the foreign vaccine to enter the market
    • 3 Vaccination of vaccine may occur when it is available in the market
    • 4 The vaccine is still falling short for those above 45 years

    The crisis of corona epidemic in the country is constantly deepening. The unprecedented increase in the cases of Kovid-19 infection and the death toll due to corona have shocked everyone. Health systems have collapsed across the country. People are suffering from lack of beds, oxygen and Remedisvir injections in hospitals. Amidst all this, the central government has decided to start anti-coronation vaccination for all people above 18 years of age from May 1. After this decision of the central government, all people above the age of 18 years will be eligible to get the vaccine. But, this vaccine will be available to these people from the state governments or in the market.

    The companies producing the vaccine can sell 50 percent of the total vaccine to the central government and the remaining 50 percent to the state governments or in the market. After this decision, the central government has pulled out of providing vaccines in large quantities to the state governments. The central government will provide vaccines according to their requirement to the state governments out of 50 per cent vaccines. At the same time, the responsibility of purchasing the remaining 50 percent vaccines has been placed on the state governments. However, the central government will continue to allocate the vaccine to the states on the basis of the procedure as before. After the latest decision of the Central Government, the question arises that how will the vaccine be provided to people above 18 years of age?

    Vaccine availability big crisis

    Prime Minister Narendra Modi has said to increase the production of anti-coronary vaccine. However, the situation seems to be quite the opposite. The possibility of an increase in vaccine production amid the second wave of the Corona epidemic is slim. The production of Covishield of Serum Institute is only from 6 to 7 crores. The US has banned the supply of raw materials needed to make the serum institute a vaccine. Due to which the production of Kovishield is not likely to increase. According to the current production capacity of Bharat Biotech Kovaxin, only 200 million doses can be produced in a year. The central government has opened the way for vaccination for people above 18 years, but from where vaccines will be available for vaccination, the central government has no answer on this.

    It may take time for the foreign vaccine to enter the market

    The recent decision of the central government is clear that it will continue to vaccinate people above the age of 45 years. The responsibility of vaccinating people above 18 years is entirely on the state governments. Currently, only Kovaxin and Kovishield vaccines are available in India. Sputnik-V has been approved by the Central Government for use in an emergency, but the doubt remains on how long its production will start on a large scale. The condition of the vaccine of other countries is also the same. Foreign vaccine producing companies will not cancel their earlier orders for India from other countries. Trials of many foreign vaccines are going on in India, but the results of the trials may take a few months. Many vaccine trials are in the final stages. In a way, the central government has put the responsibility of getting vaccinations of people above 18 years and the purchase of vaccines on the shoulders of the state government.

    Vaccination of vaccine may occur when it is available in the market

    With the availability of anti-coronary vaccines in the market, the possibilities of its black marketing cannot be ruled out. As Remadecivir injection, which acts as a life-saving for Corona patients, is being black marketed, the same condition of Corona vaccines seems to be happening. People will try to get Corona vaccine under any circumstances and in this situation the chances of getting vaccine brokerage in private hospitals are much more.

    The vaccine is still falling short for those above 45 years

    According to the Health Ministry data, more than 12.71 crore people have been vaccinated in the country so far. Out of these, about 10.96 crore people have got the first dose of vaccine and about 1.74 crore people have got the second dose of vaccine. The central government still needs 46 crore vaccine doses to complete vaccination for frontline workers and people above 45 years of age. In this situation, it will be interesting to see how people above 18 years will get the vaccine.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleIPL 2021: Know Why Virat Kohli Threatened To Throw Mr. Nags From The Plane
    Next Article 11 Scams And Secrets Of Bollywood That Shocked Everyone
    Shavvy
    Shavvy
    • Facebook
    • Instagram

    A creative writer with strong zest of blogging, traveling, food and wander.

    Next Up For You

    Technology

    CoinDCX Introduces 'Earn' Feature on USDD, Up to 8% APR for Indian Crypto Investors

    December 11, 2025
    Technology

    ZebPay Marks 11 Years of Leading Bitcoin Investments in India; Unveils New Brand Identity

    December 6, 2025
    Technology

    CoinSwitch Releases India's First Comprehensive VDA Handbook for Police and LEAs

    December 6, 2025
    Technology

    CoinEx Charity and Seerakku Lead 2,000 Palm Seeds Plantation in Ambattur Lake

    December 6, 2025
    Technology

    CoinSwitch Becomes India's First Crypto Platform to Cross 2.5 Crore Users

    December 6, 2025
    Technology

    Glossi Token Set to Revolutionize Crypto in 2025 with AI, Metaverse, and DeFi Innovations

    December 6, 2025
    More Reads

    O-RAN Global PlugFest Fall 2025 Showcased Continued Evolution of Advanced Use Cases and Scenarios Featuring AI in the RAN

    December 11, 2025

    Citius TransNet Investment Trust Files Draft Offer Document with SEBI for Rs 1,340 Cr InvIT

    December 11, 2025

    CoinDCX Introduces 'Earn' Feature on USDD, Up to 8% APR for Indian Crypto Investors

    December 11, 2025

    IBM and Pearson Collaborate to Build New AI-Powered Learning Tools for Organizations and Individuals Worldwide

    December 11, 2025

    SkyFi Selected for NATO DIANA 2026 Defense Innovation Accelerator

    December 11, 2025

    Cognizant Unveils Artificial Intelligence Lab and Cognizant Moment™ Studio in Bengaluru

    December 11, 2025

    Sasken Academy Strengthens Industry-Academia Collaboration with Global Partnerships and Skill Development Initiatives

    December 11, 2025
    Facebook X (Twitter) Pinterest RSS
    • About
    • Contribute
    • Intern
    • Advertise
    • Download the App
    • Contact Us
    © 2025 PagalParrot Media.

    Type above and press Enter to search. Press Esc to cancel.